col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


226 Results       Page 1

 [1] 
Ovid: Journal of Hypertension
  original article Date Title Authors   All Authors
1 [GO] 2023―Sep―08 Increased blood pressure after nonsevere COVID-19 Christian Schmidt-Lauber, Elisa Alba Schmidt, Sonja Hänzelmann, Elina L. Petersen, Christian-Alexander Behrendt, Raphael Twerenbold, et al. (+3)
2 [GO] 2023―Jun―20 Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign Thomas Beaney, Wei Wang, Markus P. Schlaich, Aletta E. Schutte, George S. Stergiou, Luis Alcocer, et al. (+13)
3 [GO] 2023―Jun―08 USE OF ANTIHYPERTENSIVE DRUG CLASSES DURING THE COVID-19 PANDEMIC. A CROSS-SECTIONAL, NATION-WIDE STUDY 2019-2021 Piotr Dobrowolski, Aleksander Prejbisz, Gabriel Bozek, Beata Kon, Aneta Machnie, Filip Urbanski, et al. (+4)
4 [GO] 2023―Jun―08 ASSOCIATION BETWEEN MASKED NOCTURNAL HYPERTENSION AND DEPRESSION DISORDER IN COVID-19 POSITIVE PATIENTS Jong Hoon Koh, Miyoung Kim, Minjong Kang
5 [GO] 2023―Jun―08 EFFECT OF COVID-19 ON BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS Silviu Ionel Dumitrescu, Alice Munteanu, Silviu Stanciu, Ileana Hantulie, Raluca Popescu, Magdalena Gurzun, et al. (+5)
6 [GO] 2023―Jun―08 USE OF ANTIHYPERTENSIVE COMBINATION THERAPY DURING THE COVID-19 PANDEMIC - A CROSS-SECTIONAL, NATION-WIDE STUDY 2019-2021 Piotr Dobrowolski, Aleksander Prejbisz, Gabriel Bozek, Beata Kon, Aneta Machnio, Filip Urbanski, et al. (+4)
7 [GO] 2023―Jun―08 ENDOTHELIAL FUNCTIONAL STATUS IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES MELLITUS AFTER COVID-19 Jamol Uzokov, Bakhromkhon Alyavi, Daler Orziev, Shakhboz Ubaydullaev
8 [GO] 2023―Jun―08 CARDIAC REMODELING IN HYPERTENSIVE PATIENTS WITH COVID-19: PRE-DISCHARGE ASSESSMENT AND A 1-MONTH FOLLOW-UP Oleksii Honchar
9 [GO] 2023―Jun―08 PRE-DISCHARGE SYSTOLIC BLOOD PRESSURE IN HOSPITALIZED COVID-19 PATIENTS IS AN INDEPENDENT PREDICTOR OF IMROVEMENT IN 6-MINUTE WALK TEST DURING 1-MONTH FOLLOW-UP Oleksii Honchar, Tetyana Ashcheulova
10 [GO] 2023―Jun―08 THE IMPACT OF COVID-19 PANDEMIC ON BLOOD PRESSURE CONTROL IN PATIENTS WITH TREATED HYPERTENSION. RESULTS OF EUROPEAN SOCIETY OF HYPERTENSION STUDY (ESH ABPM COVID-19 STUDY) Wiktoria Wojciechowska, Marek Rajzer, Thomas Weber, Marzena Chrostowska, Michalis Doumas, Jean -Baptiste De Fréminville, et al. (+14)
11 [GO] 2023―Jun―08 THE IMPACT OF HYPERTENSION AND OTHER COMORBIDITIES ON THE SEVERITY AND OUTCOME OF COVID-19 INFECTION IN SUDANESE HOSPITALIZED PATIENTS AT JABRA ISOLATION CENTRE 2021 Hind Beheiry, Marwa Elhassan, Zakarya Almarrani, Shehab Hazaa, Gaafar Abdulsamad, Doaa Ahmed, et al. (+10)
12 [GO] 2023―Jun―08 COMORBIDITIES AND MORTALITY IN PATIENTS WITH COVID-19 AMONG AGED 18 YEARS AND OLDER IN DILCHORA HOSPITAL-DIRE DAWA, EASTERN ETHIOPIA, 2022 Dagmawi Abebe Ayele, Hirbo Shore Roba
13 [GO] 2023―Jun―08 COVID-19 AND MORTALITY IN HYPERTENSIVE PATIENTS ACCORDING TO CARDIORESPIRATORY FITNESS Charles Faselis, Michael Doumas, Andreas Pittaras, Immanuel Babu Samuel, Belinda Gorsuch, Alexandros Ladas, et al. (+3)
14 [GO] 2023―Jun―08 EFFECT OF THE PERIOD OF THE COVID-19 PANDEMIC ON HYPERTENSIVE PEOPLE: A PROSPECTIVE COHORT STUDY Mayra Cristina Luz Pádua Guimarães, Juliano Santos, Juliana Chaves Coelho, Cassia Lima De Campos, Giovanio Vieira da Silva, Luciano Ferreira Drager, Angela Maria Geraldo Pierin
15 [GO] 2023―Jun―08 THE IMPACT OF THE 3-YEAR COVID-19 PANDEMIC IN THE HYPERTENSIVE POPULATION OF A EUROPEAN SOCIETY OF HYPERTENSION EXCELLENCE CENTER Helen Triantafyllidi, Dionyssia Birmpa, Dimitrios Benas, Anastasia Fambri, Dimitra Kavatha, Efstathios Iliodromitis
16 [GO] 2023―Jun―08 CLINICAL CONSEQUENCES IN POST COVID-19 HYPERTENSIVE PATIENTS Olena Matova, Larysa Mishchenko, Tatyana Talaeva, Volodymyr Bezrodnyj, Galina Bozhenko
17 [GO] 2023―Jun―08 POST HOC ERGO PROPTER HOC? NOT EVERYTHING THAT HAPPENS AFTER COVID-19 IS LONG COVID. OR, THE MANY MASQUERADES OF PHEOCHROMOCYTOMA Agnieszka Kuzior, Carlos Rios-Gomez, Borja Ojeda-Santana, Ricardo Jose de Leon-Durango, Alba Hernandez-Lazaro, Claudia Arnas-Leon, et al. (+6)
18 [GO] 2023―Jun―08 COVID-19 AND ARTERIAL STIFFNESS IN VACCINATED YOUNG ADULTS WITHOUT PRIOR CO-MORBIDITIES. A CROSS-SECTIONAL ANALYSIS OF THE FIT@4COVID COHORT STUDY Telmo Pereira, Fábio Lira, Armando Caseiro, Joaquim Castanheira, Manuel Coelho-e-Silva
19 [GO] 2023―Jun―08 IMPACT OF THE COVID-19 PANDEMIC ON THE TREATMENT AND ADHERENCE OF HYPERTENSIVE PATIENTS: CHALLENGES AND OUTCOMES Roxana Pleava, Ilze Vinkele, Svetlana Mosteoru, Laura Gaita
20 [GO] 2023―Jun―08 DO RENIN-ANGIOTENSIN SYSTEM INHIBITORS HAVE ANY EFFECT ON THE SEVERITY OF COVID-19 IN HYPERTENSIVE SUBJECTS? Javier Nieto, José Abellán-Alemán, Maravillas Sánchez-Macarro, Ángeles Velasco-Soria, Rafael Crespo-Sabaris, Fernando García-Romanos, et al. (+6)
21 [GO] 2023―Jun―08 ONGOING ANTI-HYPERTENSIVE TREATMENT DOESN’T IMPACT ON OUTCOME ON MEDIUM-LONG TERM SEQUELAE OF PATIENTS WITH MODERATE TO SEVERE COVID-19 PNEUMONIA Chiara Cattaneo, Francesca Salvotti, Francesca Leidi, Riccardo Pellegrinelli, Veronica Geroldi, Giorgia Loro, et al. (+10)
22 [GO] 2023―Jun―08 UNCONTROLLED BLOOD PRESSURE BEFORE COVID-19 IS ASSOCIATED WITH ELEVATED SERUM IL-17 AND LONG-COVID SEQUELAE IN HEMODIALYSIS PATIENTS Natalia Stepanova, Victoria Driianska, Andriy Rysyev, Tetyana Ostapenko, Nataliia Kalinina, Victoria Savchenko, Mykola Kolesnyk
23 [GO] 2023―Jun―08 HYPERTENSION AND RISK FACTOR TO MORTALITY IN CORONAVIRUS DISEASE (COVID-19) Monica Amorim de Oliveira, Andréa Haddad, Alessandra Godomiczer, Thaisa Rodrigues Garcia, Camila Sten, Flavia Pedro Moisés, et al. (+2)
24 [GO] 2023―Jun―08 PROTECTIVE EFFECTS OF CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE NON-VACCINATED PATIENTS WITH COVID-19 Milovan Stojanovic, Marina Deljanin Ilic, Ljiljana Trickovic, Sanja Stojanovic, Stevan Ilic
25 [GO] 2023―Jun―08 THE IMPACT OF ON-ADMISSION SYSTOLIC BLOOD PRESSURE READING ON THE SEVERITY AND CLINICAL OUTCOME OF HYPERTENSIVE COVID-19 HOSPITALIZED PATIENTS AT JABRA ISOLATION CENTRE/SUDAN: A CROSS-SECTIONAL HOSPITAL-BASED STUDY (2021) Hind M. Beheiry, Waleed M. Alhaj, Mohammed H. Jaber, Hazim H. Mohamed, Mohannad A. Almahie, Amjad M. Ahmed, et al. (+2)
26 [GO] 2023―Jun―08 DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND IN-HOSPITAL OUTCOME OF HYPERTENSIVE COVID-19 POSITIVE PATIENTS Md Kalimuddin, Fazila-Tun-Nesa Malik, Mir Ishraquzzaman, Nazir Ahmed, Mohammad Badiuzzaman, Mir Nesaruddin Ahmed, et al. (+4)
27 [GO] 2023―Jun―08 HYPERTENSIVE EMERGENCIES AND BLOOD PRESSURE CONTROL DURING THE COVID-19 PANDEMIC Ricardo Cabrera Solé, Caridad Turpin, Erik Luepke, Manuel Aguilera
28 [GO] 2023―Jun―08 COVID-19: RISK AND CARDIOVASCULAR DISEASE. SYSTEMATIC REVIEW 2022 Eulalia Amador Rodero, Santiago Rodriguez Miranda, Ana Maria Segura, Leslie Montealegre Esmeral, Martha Arteta Charris
29 [GO] 2023―Jun―08 ARTERIAL HYPERTENSION AND COVID-19: A RETROSPECTIVE STUDY Nino Latsabidze
30 [GO] 2023―Jun―08 LACK OF CARDIOVASCULAR EVENTS AFTER ONE YEAR FOLLOW-UP IN PATIENTS FOLLOWED HOSPITAL ADMISSION FOR MODERATE TO SEVERE COVID-19 PNEUMONIA Chiara Cattaneo, Francesca Salvotti, Francesca Leidi, Riccardo Pellegrinelli, Veronica Geroldi, Fabio Cherubini, et al. (+14)
31 [GO] 2023―Jun―08 MEDICAL STUDENTS’ EVALUATION BY SERIOUS GAME IN THE ERA OF COVID-19 INFECTION Ikram Chamtouri, Walid Jomaa, Khaldoun Ben Hamda
32 [GO] 2023―Jun―08 WHEN PERCUTANEOUS CORONARY INTERVENTION (PCI) IS NOT AN OPTION - CONSERVATIVE TREATMENT OF STEMI DUE TO THE CONTRAINDICATIONS AND SEVERE COVID-19 INFECTION Edyta Zbroch, Grzegorz Adasko, Marta Cabaj, Magdalena Barano, Aleksandra Zbroch, Julia Wawiernia, et al. (+2)
33 [GO] 2023―Jun―08 WHAT HAPPENED IN THE CARDIOLOGICAL OUTPATIENT PRACTICE AFTER THE COVID-19 PANDEMIA? Ivan Gruev, Veska Tsanova
34 [GO] 2023―Jun―08 CLINICAL COURSE OF COVID-19 DEPENDING ON PRESENCE OF HYPERTENSION AND BLOOD PRESSURE CONTROL Olexandr Kuryata, Yevheniia Frolova, Olexandr Stadnyk, Viktor Semenov
35 [GO] 2023―Jun―08 COVID-19 AND CARDIOVASCULAR COMPLICATIONS. AN INAUSPICIOUS COMBINATION Edyta Zbroch, Julia Waszak, Marcin Siwik, Jakub Bazarewicz, Weronika Piotrowska, Piotr Sielatycki
36 [GO] 2023―Jun―08 COVID-19 INFECTION IN PATIENTS WITH PROVEN HEART DISEASE Christian Ngongang Ouankou, Sylvain Raoul Simeni Njonnou, Liliane Mfeukeu Kuate, Claudine Jessica Yondo Ndedi, Marie Ida Chemgne, Fernando Kemta Lekpa, et al. (+2)
37 [GO] 2023―Jun―08 FEATURES OF THE COURSE OF ATRIAL FIBRILLATION IN PATIENTS WITH CORONAVIRUS DISEASE Oksana Stasyshena, Oleg Sychov, Olena Romanova, Olena Marchenko
38 [GO] 2023―Jun―08 PECULIARITIES OF THE COURSE OF ATRIAL FIBRILLATION IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER A CORONAVIRUS INFECTION Oksana Stasyshena, Oleg Sychov, Olena Romanova, Taisia Getman, Olga Sribna, Tatiana Mikhalieva, Olena Marchenko
39 [GO] 2023―Jun―08 BLOCK OF THE ANGIOTENSIN PATHWAYS EFFECTS FLOW-VOLUME SPIROMETRY IN PATIENTS WITH SARS-COV-2 INFECTION Francesca Mancini, Marialuisa Sveva Marozzi, Luciana Loponte, Antonio Giovanni Solimando, Angelo Vacca, Sebastiano Cicco
40 [GO] 2023―Jun―08 CARDIOPULMONARY STATUS AND RIGHT VENTRICLE FUNCTIONALITY IN HYPERTENSIVE PATIENTS HOSPITALIZED OR NOT FOR SARS-COV-2 INFECTION Maria Kariori, Christos Fragoulis, Christina Chrysochoou, Panagiotis Tsioufis, Kalliopi Grigoriou, Panteleimon Papakonstantinou, et al. (+9)
41 [GO] 2023―Jun―08 ELECTROLYTE IMBALANCES IN THE CONTEXT OF SARS-COV-2 INFECTION IN HYPERTENSIVE PATIENTS Cristiana Grigore, Beatrice Balaceanu, Cristian Dorin Gurau, Carmen Giuglea, Ion Dina, Alice Balaceanu
42 [GO] 2023―Jun―08 EFFECTS OF SARS-COV-2 INFECTION ON THE CARDIORESPIRATORY PERFORMANCE BY HYPERTENSION STATUS Maria Kariori, Christos Fragoulis, Christina Chrysochoou, Panagiotis Tsioufis, Kalliopi Grigoriou, Panteleimon Papakonstantinou, et al. (+9)
43 [GO] 2023―May―17 Ups and downs of conducting a national representative survey on hypertension during pandemic time: main results of SEPHAR IV Maria Dorobantu, Cosmin Cojocaru, Laura Stanciulescu, Calin Pop, Cornelia Bala, Theodora Benedek, et al. (+8)
44 [GO] 2023―Apr―25 56. Survival of COVID-19 Patients with Hypertension Dana Pramudya, Decsa Medika Hertanto, Artaria Tjempakasari
45 [GO] 2023―Apr―25 25. Hypertension as the Main Comorbidity Diseases in Covid-19 Patients with Diabetes Mellitus: A Single Centre in North Sumatera, Indonesia R.A. Muzasti, M. Situmorang
46 [GO] 2023―Apr―25 12. Predicting Mortality in COVID-19 Patients with Hypertension using ECLA Score (ECG, Chest X-Ray and Laboratory Analysis) P.K. Lituhayu, A. Regina, A.F. Theno, A.D. Lamara, P.B.T. Saputra, M.J. Al-Farabi, et al. (+3)
47 [GO] 2023―Apr―25 13. Abnormal Cardiac Finding Increases Mortality Risk in Hypertensive COVID-19 Patients P.K. Lituhayu, A. Regina, A.F. Theno, A.D. Lamara, P.B.T. Saputra, M.J. Al-Farabi, et al. (+3)
48 [GO] 2023―Apr―05 Impaired β2-adrenergic endothelium-dependent vasodilation in patients previously hospitalized with coronavirus disease 2019 Luca Faconti, Bushra Farukh, Ryan J. McNally, Sally Brett, Phil J. Chowienczyk
49 [GO] 2023―Jan―12 PS-P06-1: REDUCED HEALTHCARE UTILIZATION AMONG PATIENTS WITH CHRONIC DISEASES DURING THE PANDEMIC Anuji Upekshika Gamage, Therani Gunasekera, Amala de Silva
50 [GO] 2023―Jan―12 PS-P06-2: HEALTHCARE EXPENDITURE AND CARE SEEKING PATTERNS AMONG PEOPLE WITH CHRONIC CONDITIONS DURING THE PANDEMIC Anuji Upekshika Gamage, Therani Gunasekera, Amala de Silva
51 [GO] 2023―Jan―12 PS-C16-12: IS ARTERIAL HYPERTENSION A MODIFIER OF CARDIOPULMONARY EXERCISE TEST AND ECHOCARDIOGAPHIC FINDINGS AFTER HOSPITALIZATION FOR SARS-COV-2? Maria Kariori, Christos Fragkoulis, Christina Chrysochoou, Dimitrios Konstantinidis, Ioannis Leontsinis, Ioannis Andrikou, et al. (+7)
52 [GO] 2023―Jan―12 S-39-3: ENDOTHELIAL INFLAMMATION AND DYSFUNCTION INDUCED BY SARS-COV-2 SPIKE PROTEIN 1 INVOLVE ADAM17 AND INTERFERON ACTIVATION PATHWAYS Francisco J Rios, Augusto C Montezano, Livia L Camargo, Rheure A Lopes, Ana B Garcia Redondo, Eliju Aranday Cortes, et al. (+3)
53 [GO] 2023―Jan―12 PS-C16-11: PREVALENCE AND HOSPITAL OUTCOME OF BACTERIAL CO-INFECTION IN RESPIRATORY TRACT SPECIMEN AMONG COVID 19 PATIENTS WITH SARS-COV-2 PNEUMONIA Dianne Joy Capuz Soliman
54 [GO] 2023―Jan―12 S-39-4: PLASMA FROM SARS-COV-2 PATIENTS INDUCES OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION VIA ANGIOTENSIN II TYPE 1 RECEPTOR (AT1R)/P38 MAPK PATHWAY Moudhi Almutlaq, Fatmah A Mansour, Hassan S Alamri, Fayhan Alroqi, Tlili Barhoumi
55 [GO] 2023―Jan―12 PS-C16-13: CARDIORESPIRATORY STATUS AFTER SARS-COV-2 INFECTION: THE ROLE OF HYPERTENSION AS RISK FACTOR Maria Kariori, Christos Fragoulis, Dimitrios Polyzos, Eirini Siafi, Fotis Tatakis, Ioannis Zamanis, et al. (+9)
56 [GO] 2023―Jan―12 PS-C30-12: IMPACT OF SARS-COV-2 INFECTION TO RISK AND SEVERITY OF HYPERTENSION IN PREGNANCY AND ITS OUTCOME TO THE NEW BORN I Gusti Bagus Mulia Agung Pradnyaandara, I Gde Sastra Winata, I Wayan Artana Putra
57 [GO] 2023―Jan―12 S-18-4: ACE2 IS INVOLVED IN SARS-COV-2 INDUCED ENDOTHELIAL CELL INFLAMMATION INDEPENDENT OF VIRAL REPLICATION Augusto Montezano, Livia L Camargo, Sheon Mary, Karla B Neves, Francisco J Rios, Rheure A Lopes, et al. (+8)
58 [GO] 2023―Jan―12 PS-BPC10-8: POST-VACCINATION SARS-COV-2 IGG ANTIBODY TITER IN DIALYSIS PATIENTS Sumiko Yoshida, Seijirou Tsuji, Keiko Miya, Hisato Shima, Manabu Tashiro, Tomoko Inoue, et al. (+4)
59 [GO] 2023―Jan―12 PS-R05-1: CASE REPORT: A RARE CASE OF ALVEOLAR HEMORRHAGE AFTER COVID-19 VACCINATION IN A PATIENT WITH RENAL-LIMITED ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS Ken Nishioka, Shintaro Yamaguchi, Itaru Yasuda, Norifumi Yoshimoto, Daiki Kojima, Kenji Kaneko, et al. (+9)
60 [GO] 2023―Jan―12 PS-C16-6: POSTAL MEDICINE DELIVERY FOR STAGE-2 HYPERTENSIVE PATIENTS IN COVID-19 SITUATION: TURNING CRISIS TO OPPORTUNITY Thapanawong Mitsungnern, Sathorn Ponpong, Nipa Udonjarut, Supap Imoun, Praew Kotruchin
61 [GO] 2023―Jan―12 PS-C16-5: RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS AND CLINICAL OUTCOMES IN COVID-19 PATIENTS WITH HYPERTENSION:A REPORT OF THREE PEAK WAVE PERIODS IN SEMARANG, INDONESIA Niyata Hananta Karunawan, Iin Irnawati Jusuf, Alvin Tonang, Prihatin Iman Nugroho
62 [GO] 2023―Jan―12 PS-C16-7: ASSOCIATION OF ELECTROCARDIOGRAM FINDINGS WITH MORTALITY IN COVID-19 PATIENTS Achilles Aquino, Marian Lopez
63 [GO] 2023―Jan―12 PS-P06-3: TREATMENT SEEKING BEHAVIOUR AND TRIGGERS AMONG PATIENTS WITH CHRONIC ILLNESSES DURING COVID-19 PANDEMIC: A QUALITATIVE STUDY Anuji Gamage, Therani Gunasekera, Sridharan Sathasivam
64 [GO] 2023―Jan―12 PS-C16-14: EFFECT OF THE COVID-19 PANDEMIC ON AMBULATORY BLOOD PRESSURE MEASUREMENT Daryl Tcheutchoua Nzokou, Martin Chaumont, Philippe Van de Borne
65 [GO] 2023―Jan―12 PS-C13-3: MORTALITY RATE AND REDUCTION OF HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION IN RESEARCH INSTITUTE OF CARDIOLOGY<RIC>,BAKU IN COVID-19 PANDEMIC Zaur Ismayil Gasimov, Gulnaz Dadashova, Tarana Javadova, Tavakkul Yusifov
66 [GO] 2023―Jan―12 PS-C16-8: CONSEQUENCES OF DISCONTINUING ANTIHYPERTENSIVE TREATMENT DURING THE FIRST WAVE OF A COVID-19 PANDEMIC Anna Vachulova, Lubos Urban, Slavomira Filipova
67 [GO] 2023―Jan―12 S-42-6: COVID-19 MORTALITY CORRELATES WITH CHRONIC DISEASE BURDEN AMONG COUNTRIES’ ONGOING SOCIAL DEVELOPMENT Shuichiro Araki
68 [GO] 2023―Jan―12 JS-MT-1: MAINTAINING AN ACTIVE RESEARCH CAREER DURING COVID-19 LOCKDOWNS Yugeesh R Lankadeva
69 [GO] 2023―Jan―12 PS-C16-4: COMPARATIVE EFFICACY OF VARIOUS ANTICOAGULANTS IN COVID-19 INDIAN SUBJECTS: AN OBSERVATIONAL STUDY Hariharan Ranga Satya Munganda, Dnyanesh Amle, Satyanarayana Chowdary Ponnaganti, Gopalakrishna Murthy Tirumalsetty, Aparna Devi Vvl
70 [GO] 2023―Jan―12 PS-P12-11: INFECTION CONTROL PRACTICES OF HEALTHCARE WORKERS INFECTED WITH COVID-19 IN TONDO MEDICAL CENTER FROM MARCH 2020 TO MAY 2021 Sheryl Joy Esteban Gracilla, Joseph Quebral
71 [GO] 2023―Jan―12 PS-BPC06-4: RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS VERSUS CALCIUM CHANNEL BLOCKERS IN ASSOCIATION WITH MORTALITY RATE IN COVID-19 HYPERTENSIVE PATIENTS: THE EFFECT OF AGE Dina Ahmed Hassan, Maha Ismail Elamin, Intisar Abdelrahim Bashir, Tarig Elhadi Mahmoud
72 [GO] 2023―Jan―12 S-39-5: FACTORS AFFECTING DEVELOPMENT OF AKI AMONG COVID-19 HYPERTENSIVE PATIENTS Intisar Abdelrahim Bashir Omer, Maha Esmail Elamin, Dina Ahmed Hasan
73 [GO] 2023―Jan―12 S-39-1: COVID-19 AND HYPERTENSION IN JAPAN, AND KANAGAWA RASI COVID-19 STUDY Kouichi Tamura, Yasushi Matsuzawa, Kazuo Kobayashi
74 [GO] 2023―Jan―12 PS-BPC06-1: RENIN-ANGIOTENSIN SYSTEM BLOCKER AND THE COVID-19 AGGRAVATION: REPORT BY THE COVID-19 REGISTRY JAPAN Fumiki Yoshihara, Hiroshi Ohtsu, Michikazu Nakai, Shinya Tsuzuki, Kayoko Hayakawa, Mari Terada, et al. (+4)
75 [GO] 2023―Jan―12 PS-C16-2: ASSESS THE TREATMENT ADHERENCE OF ANTIHYPERTENSIVE MEDICATIONS DURING COVID-19, A MULTICENTER CENTER STUDY OF PAKISTAN Mudassar Iqbal Arain, Eduardo Fricovsky, Saira Shahnaz, Ramesha Anwar
76 [GO] 2023―Jan―12 PS-C16-3: HYPERTENSION AND RISK FACTORS ASSOCIATED WITH IN-HOSPITAL DEATH IN PATIENTS WITH COVID-19 maha Ismail Elamin, Dina Ahmed Hassan, Intisar Abdelrahim Bashir, Tarig E Mahmoud
77 [GO] 2023―Jan―12 APSH-OP-1: THERAPEUTIC TARGET AND CLINICAL IMPACT OF DAY-TO-DAY BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS WITH COVID-19 Gusti Ngurah Prana Jagannatha, AA Ayu Dwi Adelia Yasmin, I Wayan Agus Surya Pradnyana, Stanly Kamardi, Elionardo Enrique Pangkahila
78 [GO] 2023―Jan―12 AW-NI-1: ANGIOTENSIN II EXAGGERATES SARS-COV-2 SPECIFIC T-CELL RESPONSE IN CONVALESCENT INDIVIDUALS FOLLOWING COVID-19 Moudhi Almutlaq, Fatmah A Mansour, Hassan S Alamri, Fayhan Alroqi, Tlili Barhoumi
79 [GO] 2023―Jan―12 PS-C16-1: COURSE OF ACS IN PATIENTS CO-INFECTED WITH COVID-19 Khurshid Fozilov, Bakhtiyor Atamuratov, Bakhtiyor Yuldashov, Sherzod Butaev, Alisher Yuldashov
80 [GO] 2022―Sep―02 Coronavirus disease 2019 infection and subsequent cardiovascular complications Tomoyuki Kawada
81 [GO] 2022―Aug―11 The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment Alimamy Umaru Kabia, Ping Li, Zhichao Jin, Xiaojie Tan, Yilong Liu, Yuqi Feng, et al. (+4)
82 [GO] 2022―Aug―09 Stay alert about coagulation parameters - implications of thrombosis treatment in COVID-19: Erratum
83 [GO] 2022―Aug―09 Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: a systematic review Giovanni Tossetta, Sonia Fantone, Nicola delli Muti, Giancarlo Balercia, Andrea Ciavattini, Stefano Raffaele Giannubilo, Daniela Marzioni
84 [GO] 2022―Jun―28 Severe COVID-19 infection and cardiovascular disease - a long-term relationship or short myocardial affair? Manish Motwani
85 [GO] 2022―Jun―14 ENDOTHELIAL COMPLICATIONS IN HYPERTENSIVE PATIENTS WITH OBESITY OR NORMAL BODY WEIGHT AFTER COVID-19 Izolda Kokaeva, Yulia Zhernakova, Natalia Blinova, Eugenia Elfimova, Olga Pogorelova, Maria Tripoten, Irina Chazova
86 [GO] 2022―Jun―14 ASSOCIATION OF IN-PATIENT OUTCOMES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR USE AMONG HYPERTENSIVE PATIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19) Ma. Cecilia Lozada, Henry Medina, Ma Sergia Fatima Sucaldito, Lourdes Ella Santos, Deborah Ignacia David-Ona, Raymond Oliva
87 [GO] 2022―Jun―14 THE PROGNOSTIC VALUE OF THE BIOLOGICAL PROFILE OF INFLAMMATION AND COAGULATION AT HYPERTENSIVE PATIENTS AFTER COVID-19 Adrian Gavrila
88 [GO] 2022―Jun―14 THE FEATURE OF ATRIAL FIBRILLATION OCCURRENCE AND PROGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION, WHO HAVE UNDERGONE COVID-19 Lusine Hazarapetyan, Svetlana Grigoryan, Parunak Zeveian
89 [GO] 2022―Jun―14 ARTERIAL HYPERTENSION FOLLOWING COVID-19 Didi Delalic, Juraj Jug, Vamsi Varahabhatla, Ingrid Prkacin
90 [GO] 2022―Jun―14 OPTIMIZATION OF BLOOD PRESSURE CONTROL AND ANGIOPROTECTION WITH FIXED COMBINATION OF LISINOPRIL + AMLODIPINE + ROSUVASTATIN IN PATIENTS AFTER A COVID-19 Sergey Nedogoda, Alla Ledyaeva, Elena Chumachek, Vera Tsoma, Alla Salasyuk, Viktoriya Lutova, et al. (+5)
91 [GO] 2022―Jun―14 IMPAIRED BETA-2ADRENERGIC ENDOTHELIUM-DEPENDENT VASODILATION IS REVERSED BY PHOSPHODIESTERASE INHIBITION IN PATIENTS PREVIOUSLY HOSPITALIZED WITH COVID-19 Luca Faconti, Bushra Farukh, Ryan McNally, Sally Brett, Philip Chowienczyk
92 [GO] 2022―Jun―14 DYNAMICS OF ECHOCARDIOGRAPHY CHARACTERISTICS OF THE MYOCARDIUM IN PATIENTS WITH CONFIRMED DIAGNOSIS OF COVID-19 Larisa Minushkina, Tatyana Davydova, Natalya Chuprik, Anna Snigirova
93 [GO] 2022―Jun―14 STAY ALERT ABOUT COAGULATION PARAMETERS - IMPLICATIONS OF THROMBOSIS TREATMENT IN COVID-19 Piotr Sielatycki, Edyta Zbroch, Martyna Markowska, Aleksandra Zalewska, Aleksandra Bowtruczuk, Jedrzej Warpecowski, Malgorzata Gryciuk
94 [GO] 2022―Jun―14 ELEVATED RESTING HEART RATE AS INDEPENDENT IN-HOSPITAL PROGNOSTIC MARKER IN COVID-19 Gino Serravalle, Jennifer Vanoli, Raffaella Dell’Oro, Giacomo Marro, Rita Facchetti, Fosca Quarti-Trevano, et al. (+2)
95 [GO] 2022―Jun―14 COLCHICINE FOR THE PREVENTION OF COVID-19 “HARD” OUTCOMES: ALL THAT GLITTERS IS NOT GOLD. AN UPDATED ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Imprialos, Konstantinos Stavropoulos, Christodoulos Papadopoulos, Michael Doumas
96 [GO] 2022―Jun―14 TREATMENT WITH BLOCKERS OF THE RENIN-ANGIOTENSIN SYSTEM DOES NOT AFFECT RENAL FUNCTION IN PATIENTS WITH SEVERE COVID-19 ADMITTED TO INTENSIVE CARE UNIT Francesco Salvo, Elisa Gallo, Anna Botto, Alessio Risoli, Paolo Parola, Rita Tenio, et al. (+4)
97 [GO] 2022―Jun―14 COVID-19 AND CARDIOVASCULAR SYSTEM: NOT ONLY HEART BUT ALSO VASCULAR. THE EFFECTS OF THE INFECTION ON ARTERIAL STIFFNESS Alessandro Maloberti, Elena Gualini, Sara Scarpellini, Michela Algeri, Marco Biolcati, Enzo Grasso, et al. (+4)
98 [GO] 2022―Jun―14 COVID-19 AND NEW ONSET HYPERTENSION Evgeniya Shalaeva, Maksuda Shamsutdinova, Alisher Shadmanov, Shukhrat Boymuradov, Feruza Azizova, Dilshod Allaberganov, et al. (+2)
99 [GO] 2022―Jun―14 COVID-19 ASSOCIATED REDUCTION IN HYPERTENSION-RELATED DIAGNOSTIC AND THERAPEUTIC PROCEDURES IN EXCELLENCE CENTERS OF THE EUROPEAN SOCIETY OF HYPERTENSION Thomas Weber, Reinhold Kreutz, Andrzej Januszewicz, Christopher Mayer, Konstantinos Tsioufis, György Abraham, et al. (+5)
100 [GO] 2022―Jun―14 GLOMERULAR HYPERFILTRATION MAY CONTRIBUTE TO RENAL TROPISM AND KIDNEY INJURY IN COVID-19 BY UPREGULATING ACE2 IN HUMAN PODOCYTES Juliane Bolbrinker, Eva Mangelsen, Aikaterini Kourpa, Kaiser Debora, Panakova Daniela, Kreutz Reinhold
101 [GO] 2022―Jun―14 THE COURSE OF ATRIAL FIBRILLATION AFTER A PREVIOUS INFECTION WITH COVID-19 DEPENDING ON THE PRESENCE OF ARTERIAL HYPERTENSION Oleg Sychov, Oksana Stasyshena, Olena Ilchyshyna, Yu Zinchenko, Taisiya Getman, Olena Romanova, Olga Sribna
102 [GO] 2022―Jun―14 COVID-19 IMPACT ON THE PREVALENCE OF SUBCLINICAL HYPERTENSION AMONG PRACTICALLY HEALTHY MEDICAL STUDENTS Yulia Yufereva, Oleg Shevchenko, Leonid Ginzburg, Artem Zakirzyanov, Alex Shevchenko
103 [GO] 2022―Jun―14 DETERMINANTS OF OUTCOME OF MODERATE TO SEVERE COVID-19 IN A HOSPITAL SETTING: A COMPARISON BETWEEN FIRST AND SECOND/THIRD WAVE IN LOMBARDY Gianluca Boari, Francesca Leidi, Beatrice Accordini, Federico Napoli, Chiara Ghidelli, Giulia Archenti, et al. (+18)
104 [GO] 2022―Jun―14 COVID-19 INFECTION AND ARTERIAL HYPERTENSION - A RECIPROCAL INTERACTION? Filipa Ferreira Rodrigues, Juliana Sá
105 [GO] 2022―Jun―14 COVID-19 IS ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION: A META-ANALYSIS OF OBSERVATIONAL STUDIES Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Stavropoulos, Konstantinos Imprialos, Asterios Aidinis, Asimina Sviggou, et al. (+4)
106 [GO] 2022―Jun―14 ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS AS A RISK FACTOR FOR PATIENTS HOSPITALIZED WITH COVID-19. IS THAT TRUE? Paula Luque, Luis Castilla-Guerra, Maria Ferrary, Nieves Sanchez, Maria Alegre, Eduardo Carmona, Miguel Angel Rico
107 [GO] 2022―Jun―14 SELF-REPORTED CHANGE IN (UN)HEALTHY BEHAVIOURS OF PATIENTS WITH CARDIOVASCULAR DISEASES DURING THE SECOND COVID-19 LOCKDOWN IN NORTHERN GREECE: FOCUS ON DIABETES Antonios Ioannidis, Apostolos Pechlevanis, Afroditi Fragkiskou, Filio Asmani
108 [GO] 2022―Jun―14 PHYSICAL ACTIVITY AND LIFESTYLE CHANGES IN ITALY DURING THE COVID-19 LOCKDOWN: GENDER DIFFERENCES Alessio Pellegrino, Martina Rosselli, Melissa Orlandi, Maria Boddi, Laura Stefani, Loira Toncelli, Pietro Amedeo Modesti
109 [GO] 2022―Jun―14 ASSESSMENT OF ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN A POPULATION OF ARGENTINA DURING THE COVID-19 PANDEMIC Nicolas Renna, Emiliano Diez, Sergio Vissani, Beder Farez, Viviana Sorasio, Belen Camaño, et al. (+3)
110 [GO] 2022―Jun―14 LEVERAGING TECHNOLOGY TO SUPPORT PEOPLE LIVING WITH HYPERTENSION AND DIABETES DURING THE COVID-19 PANDEMIC Aima Adebo Uagboe, Ayoposi Ogboye, Maria Moosa Munee, Km Jawadur Rahman, Jonas Kofi Akpakli, Nneka Mobisson
111 [GO] 2022―Jun―14 BLOOD PRESSURE CONTROL RATES PREVIOUS AND DURING THE COVID-19 PANDEMIC IN BRAZIL Lucas Lima, Priscila Vitorino, Suelen Silva, Ana Sousa, Weimar Barroso
112 [GO] 2022―Jun―14 IMPACT OF THE COVID-19 PANDEMIC ON THE INITIATION OF ANTIHYPERTENSIVE DRUG THERAPY IN FRANCE Valérie Olié, Clemence Grave, Philippe Tuppin, Thomas Lesuffleur, Charles Guenancia, Jacques Blacher, Amélie Gabet
113 [GO] 2022―Jun―14 EFFECT OF THE COVID-19 PANDEMIC ON THE NYCHTHEMERAL BLOOD PRESSURE PROFILE Daryl Tcheutchoua Nzokou, Phillipe van de Borne, Martin Chaumont
114 [GO] 2022―Jun―14 LATVIA’S DOCTORS EXPERIENCE ON PROVIDING REMOTE CONSULTATIONS DURING COVID-19 PANDEMICS Aleksandra Jeniceka, Dzintra Homka, Ieva Bikava, Sevinç Elif Sen, Emma Sokolova
115 [GO] 2022―Jun―14 CONTINUOUS REMOTE PATIENT MONITORING SHOWS EARLY CARDIOVASCULAR CHANGES IN COVID-19 PATIENTS Arik Eisenkraft
116 [GO] 2022―Jun―14 CONTINUES REMOTE CARDIAC MONITORING IN CRITICALLY ILL COVID-19 PATIENTS (C3 STUDY) Avinash Hanbe Rajanna, Jeetendra Kumar
117 [GO] 2022―Jun―14 IMPACT OF ARTERIAL HYPERTENSION AND ANTIHYPERTENSIVE PHARMACOTHERAPY ON IN-HOSPITAL MORTALITY IN COVID-19 PATIENTS: THE CRACOV-HHS STUDY Wiktoria Wojciechowska, Michal Terlecki, Marek Klocek, Andrzej Januszewicz, Tomasz Grodzicki, Reinhold Kreutz, Marek Rajzer
118 [GO] 2022―Jun―14 AORTIC STIFFNESS AND INDEXES OF DISEASE SEVERITY IN SUBJECTS WITH PREVIOUS COVID-19 PNEUMONIA: A FOLLOW-UP STUDY Valeria Baiano, Cristiana Catena, Luca Bulfone, Laura Scandolin, Antonio Vacca, Gabriele Brosolo, et al. (+6)
119 [GO] 2022―Jun―14 COVID-19 RELATED CHANGE IN DAILY LIFE OF HYPERTENSIVE PATIENTS MAY AFFECT HYPERTENSION MANAGEMENT Vasiliki Tsoutsouli, Zacharo Sachla, Kyprianos Efstathiou, Dimos Foutsitsakis, Alexander James Damianos, Konstantinos Gkogkos
120 [GO] 2022―Jun―14 SHORT-TERM BLOOD PRESSURE ALTERATIONS AFTER COVID-19 VACCINATION Elias Sanidas, Dimitrios Papadopoulos, Theoharis Anastasiou, Maria Velliou, Eftixia Michalaki, Anastasia Fotsali, et al. (+3)
121 [GO] 2022―Jun―14 ACUTE MYOCARDITIS FOLLOWING COVID-19 VACCINATION: A PECULIAR CASE SERIES Sara Corradetti, Matteo Sclafani, Raffaella Mistrulli, Giovanna Gallo, Erika Pagannone, Marco Di Girolamo, et al. (+3)
122 [GO] 2022―Jun―14 THE EFFECT OF COVID-19 VACCINE ON ARTERIAL FUNCTION Dimitrios Terentes-Printzios, Vasiliki Gardikioti, Eirini Solomou, Eleni Emmanouil, Ioanna Gourgouli, Panagiotis Xydis, et al. (+8)
123 [GO] 2022―Jun―14 FACTORS THAT INFLUENCE THE SURVIVAL RATE IN PATIENTS WITH COVID-19 WITH A PREVIOUS DIAGNOSIS OF HYPERTENSION AND/OR DIABETES: A SYSTEMATIC REVIEW Leslie Montealegre, Eulalia Amador, Tammy Pulido, Roberto Rebolledo, Lisbeth Olvera, Brenda Pacheco
124 [GO] 2022―Jun―14 SELF-ASSESSMENT OF VITAL SIGNS AND SYMPTOMS OF COVID-19: BLOOD PRESSURE MEASUREMENTS RESULTS FROM THE HYTECC STUDY André Michaud, Lyne Cloutier, Alain Vadeboncoeur, Rémi Goupil
125 [GO] 2022―Jun―14 EFFECT OF HYPERTENSION AND RAS INHIBITORS TO ADULT PATIENTS (OVER 18 YEARS OLD) WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV2) INFECTION WHO WERE ADMITTED TO HOSPital Imola Fejes, Richárd Róka, György Ábrahám, Tamás Várkonyi, Csaba Lengyel, Péter Légrády
126 [GO] 2022―Jun―14 CORONAVIRUS DISEASE-2019 IS ASSOCIATED WITH ARTERIAL STIFFNESS IMPAIRMENT: A META-ANALYSIS OF OBSERVATIONAL STUDIES Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Imprialos, Konstantinos Stavropoulos, Asimina Sviggou, Asterios Aidinis, et al. (+4)
127 [GO] 2022―Jun―14 FEATURES OF THE PARAMETERS OF RED BLOOD CELLS AND HEMOSTASIS IN PATIENTS WITH STROKES ASSOCIATED WITH CORONAVIRUS INFECTION Margarita Vitali Kruchinina, Andrey Alexandro Gromov, Vladimir Mikhail Generalov, Anna Vladimirovn Rabko
128 [GO] 2022―Jun―14 THE ROLE OF BLOOD PRESSURE LEVEL IN THE DEVELOPMENT OF ATRIAL FIBRILLATION AFTER CORONAVIRUS INFECTION Oksana Stasushena
129 [GO] 2022―Jun―14 EFFECT OF CORONAVIRUS INFECTION ON PATIENTS WITH CONTROLLED AND UNCONTROLLED ARTERIAL HYPERTENSION Anastasiya Denisova, Olga Sivakova, Tatyana Solntseva, Irina Chazova
130 [GO] 2022―Jun―14 IMMUNE DYSREGULATION INDUCED BY SPIKE PROTEIN 1 OF SARS-COV-2 INCREASES ENDOTHELIAL CELL DYSFUNCTION VIA TYPE I AND TYPE III INTERFERON ACTIVATION PATHWAYS Francisco J. Rios, Augusto C. Montezano, Livia L. Camargo, Rheure A. Lopes, Ana B. Garcia-Redondo, Eliju Aranday-Cortes, et al. (+3)
131 [GO] 2022―Jun―14 ATRIAL FIBRILLATION INCIDENCE IN SARS-COV-2 INFECTED PATIENTS: PREDICTORS AND RELATIONSHIP WITH IN-HOSPITAL MORTALITY Alessandro Maloberti, Cristina Giannattasio, Paola Rebora, Giuseppe Occhino, Nicola Ughi, Jacopo Rizzo, et al. (+11)
132 [GO] 2022―Jun―14 IMPACT OF HYPERTENSION AS AN ADDITIONAL RISK FACTOR IN CARDIORESPIRATORY STATUS OF POST SARS-COV-2 INFECTED SUBJECTS Maria Kariori, Christos Fragoulis, Dimitrios Polyzos, Ioannis Leontsinis, Kalliopi Grigoriou, Sotirios Drogkaris, et al. (+9)
133 [GO] 2022―Jun―14 CLINICAL AND MORPHOLOGICAL FEATURES OF KIDNEY DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION DIED OF SARS-COV-2 INFECTION Tatiana Makeeva, Elizaveta Zbyshevskaya, Fatima Bitakova, Vadim Erinchek, Sergey Saiganov, Oksana Zaytseva, et al. (+4)
134 [GO] 2022―Jun―14 IMPAIRED ACE2 GLYCOSYLATION AND PROTEASE ACTIVITY LOWERS SUSCEPTIBILITY TO SARS-COV-2 INFECTION IN GITELMAN/BARTTER SYNDROMES Giovanni Bertoldi, Verdiana Ravarotto, Luca Sgarabotto, Laura Gobbi, Lucia Federica Stefanelli, Lorenzo A. Calò
135 [GO] 2022―Jun―14 PARTICULARITIES OF HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME, ADMITTED FOR SARS-COV-2 INFECTION TO A CLINICAL EMERGENCY HOSPITAL Raluca Stirban, Cristiana Grigore, Doina Dragoi, Beatrice Balaceanu, Cristian-Dorin Gurau, Cornelia Voiculet, et al. (+7)
136 [GO] 2022―Jun―14 MICROCIRCULATION AND SARS-COV-2 INFECTION: A FOLLOW UP STUDY Paolo Malerba, Claudia Agabiti Rosei, Giulia Chiarini, Matteo Nardin, Alina Petelca, Andrea Gaggero, et al. (+11)
137 [GO] 2022―Jun―14 IT IS SOMETHING MAKING THE DIFFERENCE BETWEEN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME VERSUS HYPERTENSIVE PATIENTS WITHOUT METABOLIC SYNDROME IN SARS-COV-2 INFECTION? Raluca Stirban, Doina Dragoi, Cristiana Grigore, Beatrice Balaceanu, Cristian-Dorin Gurau, Cornelia Voiculet, et al. (+7)
138 [GO] 2022―Jun―14 COMPARISON BETWEEN FIRST AND SECOND/THIRD WAVE OF SARS-COV-2 MODERATE TO SEVERE INFECTION IN ELDERLY PATIENTS IN AN NORTH ITALIAN HOSPITAL SETTING Gianluca Boari, Francesca Leidi, Beatrice Accordini, Benedetta Mangili, Chiara Ghidelli, Giulia Archenti, et al. (+19)
139 [GO] 2022―Jun―14 CARDIOPULMONARY EXERCISE TEST AND ECHOCARDIOGAPHIC FINDINGS IN HOSPITALISED POST SARS-COV-2 PATIENTS: THE EFFECT OF ARTERIAL HYPERTENSION Maria Kariori, Christos Fragoulis, Christina Chrysochoou, Ioannis Leontsinis, Emmanoyil Mantzouranis, Panagiotis Iliakis, et al. (+6)
140 [GO] 2022―Jun―14 NEW ONSET OF HYPERTENSION IN PATIENTS ADMITTED FOR INFECTION WITH SARS-COV-2 VIRUS Raluca Stirban, Cristiana Grigore, Doina Dragoi, Beatrice Balaceanu, Cristian-Dorin Gurau, Cornelia Voiculet, et al. (+7)
141 [GO] 2022―Jun―14 THE IMPACT OF HYPERTENSION AND ANTIHIPERTENSIVE TREATMENTS ON PATIENTS WITH SARS-COV-2: A RETROSPECTIVE-COHORT STUDY Paula Luque, Luis Castilla-Guerra, Nieves Sanchez, Maria Delgado, Maria Alegre, Eduardo Carmona, Miguel Angel Rico
142 [GO] 2022―Jun―14 IS HOME BLOOD PRESSURE SELF MONITORING HERE TO STAY? AN EVALUATION OF PATIENT SATISFACTION WITH HOME BLOOD PRESSURE MONITORING IN A RURAL POPULATION DURING THE COVID PANDEMIC Anjali Patel, Reshma Rasheed, Ahmad Zarif, Azad Mahmod, Hajira Bibi, Imad Nazir
143 [GO] 2022―Jun―14 MUSIC THERAPY WITH HYPERTENSIVE PATIENTS DURING THE PANDEMIC PERIOD - ONLINE MEETINGS AS PART OF MULTIPROFESSIONAL TREATMENT Claudia Zanini, Diana Teixeira, Dalma Pereira, Ana Luiza L. Sousa, Weimar K.S.B. Souza
144 [GO] 2022―Jun―14 TELEMEDICINE AND HEALTH POLICY CHANGES IN RESPONSE TO RESTRICTIONS RELATED TO COVID-19 PANDEMICS IN LATVIA Sevinc Elif Sen, Emma Sokolova, Aleksandra Jeniceka, Ieva Bikava
145 [GO] 2022―May―17 42 BLOOD PRESSURE DURING INFECTION AND SERUM CREATININE CONCENTRATIONS PREDICT SEVERE DISEASE IN COVID-19 I. Gde Raka Widiana, I. Made Bagiada, Wira Mahandita
146 [GO] 2022―May―17 7 IMPACT OF DAY-TO-DAY BLOOD PRESSURE VARIABILITY TO IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19 AND EFFICACY OF ANTIHYPERTENSIVE AGENTS G.N.P. Jagannatha, I.W.A.S. Pradnyana, S. Kamardi, A.A.A.D.A. Yasmin
147 [GO] 2022―May―17 13 THE ROLE OF HYPERTENSION AS A RISK FACTOR FOR ACUTE KIDNEY INJURY IN COVID-19 AT RSUP HAJI ADAM MALIK MEDAN: A CROSS-SECTIONAL STUDY IN 2020 Mutia Chairani, Annisa Nidya Rahmatika Sitepu, Riri Andri Muzasti
148 [GO] 2022―May―17 11 NEWLY-DIAGNOSED HYPERTENSION DURING ADMISSION FOR COVID-19 CARE AND ITS SUBSEQUENT EFFECT ON OUTCOME OF TREATMENT: A PROSPECTIVE COHORT STUDY M.A. Sholehuddin, M.A.R. Firmansya, N.H.R. Ilahi, K. Wahyuni, A. Lutfiyah, W.K. Ilahi
149 [GO] 2022―May―17 25 HYPERTENSION AND MORTALITY PREDICTOR WITHIN 10 DAYS AMONG END-STAGE RENAL DISEASE WITH COVID-19 INFECTION Langgeng Perdhana, Shofa Chasani, Muchlis Achsan Udji Sofro
150 [GO] 2022―May―17 Virtual management of hypertension: lessons from the COVID-19 pandemic-International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension Nadia A. Khan, George S. Stergiou, Stefano Omboni, Kazuomi Kario, Nicolas Renna, Niamh Chapman, et al. (+10)
151 [GO] 2022―May―17 16 OBSERVING PATIENTS' NON-ADHERENCE TO HYPERTENSION CONTROL DURING COVID-19 PANDEMIC: A QUALITATIVE STUDY IN THE PUBLIC HEALTH CENTER SETTING I Putu Hendri Aryadi, Made Martha Pradnyana, Made Ayu Hapsari Dwi Ambarini, I Gusti Ayu Nila Kusumawati.
152 [GO] 2022―May―17 43 CHARACTERISTICS AND MORTALITY IN HYPERTENSIVE COVID-19 PATIENTS AT A DISTRICT HOSPITAL IN NORTH JAKARTA: A CROSS-SECTIONAL STUDY Tantika Andina, Marcel H.R. Sibarani
153 [GO] 2022―May―17 39 CHARACTERISTICS AND MORTALITY IN HYPERTENSIVE COVID-19 PATIENTS AT A DISTRICT HOSPITAL IN NORTH JAKARTA: A CROSS-SECTIONAL STUDY Tantika Andina, Marcel H.R. Sibarani
154 [GO] 2022―May―17 46 ANGIOTENSIN-CONVERTING ENZYME INHIBITORS/ANGIOTENSIN RECEPTOR BLOCKER IMPROVES CLINICAL OUTCOMES IN COVID-19 PATIENTS: A META-ANALYSIS Bayushi Eka Putra, Bambang Widyantoro, Rido Maulana, Agnes Dinar Putrinarita, Bhayu Hanggadhi Nugroho, Anwar Santoso
155 [GO] 2022―Feb―28 Cardiovascular outcome 6 months after severe coronavirus disease 2019 infection Anne G. Raafs, Mohammed A. Ghossein, Yentl Brandt, Michiel T.H.M. Henkens, M. Eline Kooi, Kevin Vernooy, et al. (+9)
156 [GO] 2022―Feb―15 The counter-regulatory arm of the renin-angiotensin system and COVID-19 Lucia Federica Stefanelli, Verdiana Ravarotto, Giovanni Bertoldi, Lorenzo A. Calò
157 [GO] 2021―Dec―10 Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients Mauro Gori, Carlo Berzuini, Emilia D’Elia, Arianna Ghirardi, Luisa Bernardinelli, Antonello Gavazzi, et al. (+15)
158 [GO] 2021―Dec―04 A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity Sakir Akin, Paula Schriek, Cees van Nieuwkoop, Rugina I. Neuman, Iwan Meynaar, Erik J. van Helden, et al. (+17)
159 [GO] 2021―Jul―02 The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation Babak Nami, Avrin Ghanaeian, Kasra Ghanaeian, Rozhin Houri, Negin Nami, Armin Ghasemi-Dizgah, Oana Caluseriu
160 [GO] 2021―Jul―02 Impact of renin-angiotensin-aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestations Alberto Palazzuoli, Kristen M. Tecson, Peter A. McCullough
161 [GO] 2021―Jul―02 SARS-CoV-2 infection and ACE2 inhibition Fabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
162 [GO] 2021―Jun―02 Cardiovascular system in the sars-CoV-2: impact of therapies Josep Redon
163 [GO] 2021―May―12 33. CHARACTERISTICS AND COMORBIDITIES OF HYPERTENSIVE PATIENTS IN SANGLAH GENERAL HOSPITAL DURING COVID-19 PANDEMIC I Wayan Agus Surya Pradnyana, Gusti Ngurah Prana Jagannatha, Stanly Kamardi, AA Ayu Dwi Adelia Yasmin
164 [GO] 2021―May―12 34. BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE PATIENTS IN SANGLAH GENERAL HOSPITAL DURING COVID-19 PANDEMIC Stanly Kamardi, Gusti Ngurah Prana Jagannatha, I Wayan Agus Surya Pradnyana, AA Ayu Dwi Adelia Yasmin
165 [GO] 2021―May―12 54. COMPARATION OF D-DIMER LEVELS IN HYPERTENSIVE AND NON-HYPERTENSIVE ADULT COVID-19 PATIENTS Tantika Andina, Daulat JPM Tampubolon
166 [GO] 2021―May―12 77. ASSOCIATION OF D-DIMER AND FIBRINOGEN LEVEL WITH MORTALITY OF HYPERTENSIVE COVID-19 PATIENTS V. Damay, C. Sugeng, O. Umboh, E. Moeis
167 [GO] 2021―May―12 70. ASSOCIATION BETWEEN HYPERTENSION AND IN-HOSPITAL MORTALITY IN COVID-19 PATIENTS Iswandy Janetputra Turu’ Allo, Badai Bhatara Tiksnadi, Pranata Priyo Prakoso, Hana Hadianty Najiyah, Mira Rahmawati, Mira Hasmirani, et al. (+3)
168 [GO] 2021―May―12 25. PRO-INFLAMMATORY MARKERS IN COVID-19 PATIENTS WITH HYPERTENSION Rizky Andhika, Rudi Supriyadi, Bachti Alisjahbana
169 [GO] 2021―May―12 68. ASSOCIATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BLOCKER DRUGS AND OUTCOMES IN COVID-19 PATIENTS WITH HYPERTENSION Mefri Yanni
170 [GO] 2021―May―12 21. THE PROFILE OF COVID-19 PATIENTS WITH HYPERTENSION AT SILOAM DHIRGA SURYA HOSPITAL FROM MAY TO NOVEMBER 2020 Epifanus Arie Tanoto, Sri Wahyuni, Abdul Halim Raynaldo
171 [GO] 2021―May―12 44. RELATIONSHIP BETWEEN HYPERTENSION AND HYPONATREMIA IN CORONAVIRUS DISEASE PATIENTS: A CROSS-SECTIONAL STUDY Ayu Pramitha Wulandari, Dhani Tri Wahyu Nugroho
172 [GO] 2021―Apr―17 Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease Gary Tse, Jiandong Zhou, Sharen Lee, Wing Tak Wong, Xintao Li, Tong Liu, et al. (+6)
173 [GO] 2021―Apr―09 IN-HOSPITAL DIURETIC USE IS ASSOCIATED WITH WORSE OUTCOME IN PATIENTS WITH COVID-19 M. Pengo, G Stefanini, C Pivato, D Soranna, G Zambra, A Zambon, et al. (+4)
174 [GO] 2021―Apr―09 ASSOCIATION OF HYPERTENSION WITH ALL-CAUSE MORTALITY AMONG HOSPITALIZED PATIENTS WITH COVID-19 Enrique Rodilla, Alberto Saura, Iratxe Jiménez, Andrea Mendizábal, Araceli Pineda-Cantedo, Elizabeth Lorenzo-Hernández, et al. (+19)
175 [GO] 2021―Apr―09 PLASMA ACE2 ACTIVITY IS INCREASED IN PATIENTS RECOVERED FROM SARS-COV-2 INFECTION: IMPLICATIONS FOR THE PROLONGED CONSEQUENCES OF COVID-19 Sheila Patel, Jennifer Juno, Wen Shi Lee, Kathleen Wragg, P. Mark Hogarth, Stephen Kent, Louise Burrell
176 [GO] 2021―Apr―09 HYPERTENSION PHENOTYPES, TARGET ORGAN DAMAGE AND STIFF ARTERIES AND SEVERITY OF COVID-19 Azra Mahmud, Nawaf Abdulaziz Alhabdan, Mohammad Hamad Alkhdiri, Ruba Alahaideb, Rajkumar Rajendrum
177 [GO] 2021―Apr―09 HYPERTENSION IS A RISK FACTOR FOR ACUTE KIDNEY INJURY AND A PREDICTOR OF MORTALITY IN HOSPITALIZED PATIENTS WITH COVID-19 Yulia Khruleva, Tapiwa Mubayazvamba, Elena Troitskaya, Marina Efremovtseva, Zhanna Kobalava
178 [GO] 2021―Apr―09 COMORBIDITIES FACTORS AND HYPERTENSION IN RELATION TO COVID-19 Jong Hoon Koh, Enjin Shim, Minjeong Kang, Inkyeong Hwang
179 [GO] 2021―Apr―09 THE PREVALENCE OF ARTERIAL HYPERTENSION AMONG PATIENTS HOSPITALIZED WITH COVID-19 Kseniia Eruslanova, Anna Akapyan, Irina Malaya, Irina Strojesko, Nikolay Leonov, Julia Kotovskaya, et al. (+2)
180 [GO] 2021―Apr―09 EVIDENCE OF A BLOOD PRESSURE REDUCTION DURING THE COVID-19 ASSOCIATED LOCKDOWN: A PLAUSIBLE EXPLANATION FOR THE OBSERVED DECLINES IN ACUTE CARDIOVASCULAR DISEASES? Nicolas Girerd, Christophe Meune, Kevin Duarte, Vincent Vercamer, Marilucy Lopez-Sublet, Jean-Jacques Mourad
181 [GO] 2021―Apr―09 LOW MOLECULAR WEIGHT HEPARIN AT HIGH DOSE IMPACTS ON OUTCOME OF COVID-19 HOSPITALIZED PATIENTS, WHILE STANDARD DOSE DOESN’T Silvia Bonetti, Gianluca E.M. Boari, Giulia Chiarini, Cristina Faustini, Gianluca Bianco, Federico Braglia-Orlandini, et al. (+2)
182 [GO] 2021―Apr―09 HYPERTENSIVE PATIENTS ON TREATMENT AND COVID-19 IN FRANCE: FLAHS 2020 SURVEY Olivier Hanon, Atul Pathak, François Silhol, Marie Catherine Wimart, Xavier Girerd
183 [GO] 2021―Apr―09 ROLE OF ACE2 GLYCOSYLATION AND RHO KINASE INHIBITION IN THE INFECTIOUS/THERAPEUTIC PROCESS OF COVID-19. INSIGHTS FROM GITELMAN'S AND BARTTER'S SYNDROMES PATIENTS Giovanni Bertoldi, Lisa Gianesello, Matteo Rigato, Luca Sgarabotto, Lorenzo Calò
184 [GO] 2021―Apr―09 IMPACT OF COVID-19 LOCKDOWN ON VASCULAR STIFFNESS TRAJECTORIES IN FRANCE AND GERMANY Rosa Maria Bruno, Jean-Louis Pepin, Jean-Philippe Empana, Rui-Yi Yang, Vincent Vercamer, Paul Jouhaud, et al. (+2)
185 [GO] 2021―Apr―09 INCREASED CARDIOVASCULAR DEATH RATES IN A COVID-19 LOW PREVALENCE AREA Rita Del Pinto, Giovambattista Desideri, Leondino Mammarella, Stefano Abballe, Sofia Dell’Anna, Sabrina Cicogna, et al. (+3)
186 [GO] 2021―Apr―09 CARDIOVASCULAR COMPLICATIONS FROM COVID-19 MAY BE PREDICTED BY THE INCREASED LEVEL OF C-REACTIVE PROTEIN: A META-ANALYSIS Elona Greca, Muhammad Shah, Krunal Pandav, Dario Dedja, Ilda Hoxhaj
187 [GO] 2021―Apr―09 ADHERENCE TO ANTI-HYPERTENSIVE TREATMENT ON THE COVID-19 PANDEMIC Mayra Cristina Luz Pádua Guimaraes, Juliana Chaves Coelho, Juliano Dos Santos, Camila Braga De Oliveira Higa, Carime Farah Florido, Renata Jae Won Lee, et al. (+3)
188 [GO] 2021―Apr―09 PATIENTS’ PERCEPTIONS ON THE USE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS DURING THE FIRST WAVE OF THE COVID-19 PANDEMIC Antonios Ioannidis, Maria Paraskelidou, Apostolos Pechlevanis, Afroditi Fragkiskou
189 [GO] 2021―Apr―09 THE IMPACT OF COVID-19 PANDEMIC AND LOCKDOWN ON CARDIOMETABOLIC STATUS ON PATIENTS WITHOUT EVIDENCE OF SARS COV-2 INFECTION IN THREE REGIONS OF LATIN AMERICA. A SUB-STUDY OF THE CORCOVID LATAM STUDY Jorge Camilletti, Nicolas Renna, Ricardo Lopez Santi, Juan Erriest, Grecia Perez Siller, Maria Isabel Garcia, et al. (+2)
190 [GO] 2021―Apr―09 THE IMPACT OF COVID-19 PANDEMIC LOCKDOWN ON HYPERTENSIVE INDIVIDUALS WITH COMORBIDITIES OF A LONGITUDINAL COHORT IN INDIA Kaushik Chakraborty, Nilanjana Chakraborty, Ramendra Nath Mitra, Dipra Mitra
191 [GO] 2021―Apr―09 PATIENTS’ PERCEPTIONS ON THE USE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS: COMPARISON BETWEEN THE FIRST AND THE SECOND COVID-19 PANDEMIC WAVES Antonios Ioannidis, Apostolos Pechlevanis, Afroditi Fragkiskou, Maria Paraskelidou
192 [GO] 2021―Apr―09 IMPACT OF REDUCTION IN AIRCRAFT NOISE EXPOSURE ON BLOOD PRESSURE AND ARTERIAL STIFFNESS DURING COVID-19 PANDEMIC: CROSS-SECTIONAL AND LONGITUDINAL STUDY Wiktoria Wojciechowska, Andrzej Januszewicz, Tomasz Drozdz, Marta Rojek, Justyna Baczalska, Michal Terlecki, et al. (+8)
193 [GO] 2021―Apr―09 CONDUCTING AN RCT IN THE COVID-19 PANDEMIC: TARGETING VULNERABILITY TO SEASONAL AND ACUTE WEATHER CHANGES TO KEEP AUSTRALIANS WITH CARDIOVASCULAR DISEASE OUT OF HOSPITAL - THE RES Nasreen Moini, Sheila K. Patel, Jay Ramchand, Jody Hook, Christine F. Mcdonald, Simon Stewart, Louise Burrell
194 [GO] 2021―Apr―09 HYPERTENSION ASSOCIATED RISKS DURING THE COVID-19 PANDEMIC: THE PATIENTS’ PERCEPTION Antonios Ioannidis, Afroditi Fragkiskou, Maria Paraskelidou, Apostolos Pechlevanis
195 [GO] 2021―Apr―09 HYPERTENSION AND COVID-19: THE POSSIBLE ROLE OF METALLOPROTEINASE-9 IN COVID-19 PATHOPHYSIOLOGY Carolina Dávila Mesquita, Ariel Emiliano Souza Do Couto, Ligia Borges Campos, Bruno Cesar Petroski Mora, Fabiola Mestriner, Tauana Fernandes Vasconcelo, et al. (+7)
196 [GO] 2021―Apr―09 ASSOCIATION OF ARTERIAL STIFFNESS WITH ALL-CAUSE MORTALITY AMONG HOSPITALIZED COVID-19 PATIENTS Enrique Rodilla, Alberto Belda, Sergio Canales, Maria Quilis, Maria Carmen Saez, Alicia Roldan, et al. (+24)
197 [GO] 2021―Apr―09 ROLE OF HYPERTENSION, CARDIOVASCULAR DISEASE AND CARDIOVASCULAR RISK FACTORS ON OUTCOME IN HOSPITALIZED COVID-19 PATIENTS Giulia Chiarini, Gianluca E.M. Boari, Silvia Bonetti, Federico Braglia Orlandini, Paolo Malerba, Gianluca Bianco, et al. (+2)
198 [GO] 2021―Apr―09 EFFECT OF ONGOING TREATMENT AND DIFFERENT THERAPIES ON PROGNOSIS IN COVID-19 PATIENTS IN AN HOSPITAL SETTING Gianluca Bianco, Gianluca E.M. Boari, Silvia Bonetti, Giulia Chiarini, Federico Braglia Orlandini, Cristina Faustini, et al. (+2)
199 [GO] 2021―Apr―09 GENDER DIFFERENCES IN COVID-19 PATIENTS WITH ARTERIAL HYPERTENSION Tiziana Ciarambino, Filippina Ciaburri, Vera Delli Paoli, Marinella D’avino, Direttivo Fadoi Campania
200 [GO] 2021―Apr―09 ROLE OF HYPERTENSION ON THE SEVERITY AND PROGRESSION OF COVID-19: A RETROSPECTIVE COHORT STUDY IN INDIA Ambily K, Tapas Sadasivan Nair
201 [GO] 2021―Apr―09 RENIN-ANGIOTENSIN SYSTEM INHIBITORS AND COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS EVIDENCE FOR SIGNIFICANT GEOGRAPHICAL DISPARITIES Dimitrios Patoulias, Alexandra Katsimardo, Konstantinos Stavropoulo, Konstantinos Imprialos, Maria -Styliani Kalogirou, Michael Doumas
202 [GO] 2021―Apr―09 LEVELS OF IMMUNOGLOBULIN G AND MARKERS OF VASCULAR INFLAMMATORY RESPONSE AS PREDICTORS OF POSSIBLE VASCULAR COMPLICATIONS IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER SARS-COV-2 Tatiana Petelina, Musikhina Natalia, Yaroslavskaya Elena, Gultyaeva Elena, Avdeeva Ksenia, Gorbatenko Elena, et al. (+3)
203 [GO] 2021―Apr―09 SKIN CAPILLARY ALTERATIONS IN PATIENTS WITH ACUTE SARS-COV-2 INFECTION Carolina De Ciuceis, Claudia Agabiti Rosei, Valeria Brami, Claudia Rossini, Andrea Gaggero, Francesca Fama’, et al. (+2)
204 [GO] 2021―Apr―09 IMPACT OF COVID 19 PANDEMIC ON BLOOD PRESSURE OF HEALTHCARE PROFESSIONALS DURING LOCKDOWN - AN INDIAN STUDY Amit Gupta, Anuj Maheshwari, Narsingh Verma, Aravinda Jagadeesha, S.S. Dariya, Amit Sharma, et al. (+9)
205 [GO] 2021―Mar―03 Lessons from COVID-19 mortality data across countries Giovanni Corrao, Federico Rea, Gian Carlo Blangiardo
206 [GO] 2021―Mar―03 Coronavirus disease 2019 and cardiovascular complications Sahrai Saeed, Marijana Tadic, Terje H. Larsen, Guido Grassi, Giuseppe Mancia
207 [GO] 2021―Feb―22 Renin-angiotensin-system inhibitors and all-cause mortality in patients with coronavirus disease 2019 Chirag Bavishi, Paul K. Whelton, Giuseppe Mancia, Giovanni Corrao, Franz H. Messerli
208 [GO] 2020―Dec―31 Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic Reinhold Kreutz, Piotr Dobrowolski, Aleksander Prejbisz, Engi A.E-H Algharably, Grzegorz Bilo, Felix Creutzig, et al. (+16)
209 [GO] 2020―Dec―04 The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension
210 [GO] 2020―Nov―17 Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during coronavirus disease 2019 Jordana B. Cohen, Lucy D’Agostino-McGowan, Elizabeth T. Jensen, Joseph Rigdon, Andrew M. South
211 [GO] 2020―Nov―04 Renin--angiotensin system blockers and the risk of critical or fatal coronavirus disease 2019 in African Americans Costas Thomopoulos, Helena Michalopoulou
212 [GO] 2020―Oct―06 Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019 Alexandre Lahens, Jimmy Mullaert, Simon Gressens, Nathalie Gault, Martin Flamant, Laurène Deconinck, et al. (+4)
213 [GO] 2020―Aug―05 Immunity, inflammation and the vasculature in the COVID-19 era Aletta E. Schutte, David G. Harrison
214 [GO] 2020―Aug―05 Association between hypertension and pneumonia caused by SARS-CoV-2 in Mexican population Akram Hernández-Vásquez, Rodrigo Vargas-Fernández, Guido Bendezu-Quispe
215 [GO] 2020―Aug―03 Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients Priyank Shah, Jack Owens, James Franklin, Yash Jani, Ashish Kumar, Rajkumar Doshi
216 [GO] 2020―Jun―05 Are COVID-19 patients with hypertension at higher risk in China? Siqi Wang, Yan Chen, Lu Wang, Huan Liu, Ping Han
217 [GO] 2020―May―30 Food protein-derived antihypertensive peptides in the COVID-19 pandemic Mostafa Goudarzi, Farhad Garavand, Ashkan Madadlou, Vincenzo Fogliano
218 [GO] 2020―May―08 Influence of inhibitors of the renin-angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients Anders Holt, Ikram Mizrak, Morten Lamberts, Per Lav Madsen
219 [GO] 2020―May―06 COVID-19, hypertension and angiotensin receptor-blocking drugs Francisco José Fernández-Fernández
220 [GO] 2020―May―06 Comment on ‘Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?’ Erkan Cüre, Medine Cumhur Cüre
221 [GO] 2020―May―06 Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
222 [GO] 2020―May―06 Hypertension and coronavirus disease 2019 Ari G. Mandler
223 [GO] 2020―May―06 Hypertension and coronavirus disease 2019 mortality Ruben Kevin A. Tapia-Orihuela
224 [GO] 2020―May―06 Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019? Di Liu, Yun-Zhao Li, Hui Wu
225 [GO] 2020―May―06 Angiotensin-converting enzyme-2 in SARS-CoV-2 infection Jorie Versmissen, Koen Verdonk, Melvin Lafeber, Johannes P.C. van den Akker, Nicole G.M. Hunfeld, Ewout J. Hoorn, A.H. Jan Danser
226 [GO] 2020―Mar―20 Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? Murray Esler, Danielle Esler
 [1] 

226 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.014 sec